Filing Details
- Accession Number:
- 0001596771-18-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-12 16:40:47
- Reporting Period:
- 2018-02-08
- Accepted Time:
- 2018-02-12 16:40:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1638287 | Gemphire Therapeutics Inc. | GEMP | Pharmaceutical Preparations (2834) | 472389984 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1674004 | Seth Reno | 17199 N. Laurel Park Drive Suite 401 Livonia MI 48152 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-08 | 14,286 | $7.00 | 18,286 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in a confidentially marketed public offering pursuant to an Underwriting Agreement. The offering closed on February 12, 2018.
Billionaire Hedge Funds
